Search Results - "Vollenweider, Franz X."

Psychometric evaluation of the altered states of consciousness rating scale (OAV) by Studerus, Erich, Gamma, Alex, Vollenweider, Franz X

“…The OAV questionnaire has been developed to integrate research on altered states of consciousness (ASC). It measures three primary and one secondary dimensions…”
Get full text

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects by Schmid, Yasmin, Enzler, Florian, Gasser, Peter, Grouzmann, Eric, Preller, Katrin H, Vollenweider, Franz X, Brenneisen, Rudolf, Müller, Felix, Borgwardt, Stefan, Liechti, Matthias E

“…Abstract Background After no research in humans for >40 years, there is renewed interest in using lysergic acid diethylamide (LSD) in clinical psychiatric…”
Get full text

Prediction of psilocybin response in healthy volunteers by Studerus, Erich, Gamma, Alex, Kometer, Michael, Vollenweider, Franz X

“…Responses to hallucinogenic drugs, such as psilocybin, are believed to be critically dependent on the user's personality, current mood state, drug…”
Get full text

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor by Preller, Katrin H, Burt, Joshua B, Ji, Jie Lisa, Schleifer, Charles H, Adkinson, Brendan D, Stämpfli, Philipp, Seifritz, Erich, Repovs, Grega, Krystal, John H, Murray, John D, Vollenweider, Franz X, Anticevic, Alan

“…Lysergic acid diethylamide (LSD) has agonist activity at various serotonin (5-HT) and dopamine receptors. Despite the therapeutic and scientific interest in…”
Get full text

Effects of serotonin 2A/1A receptor stimulation on social exclusion processing by Preller, Katrin H., Pokorny, Thomas, Hock, Andreas, Kraehenmann, Rainer, Stämpfli, Philipp, Seifritz, Erich, Scheidegger, Milan, Vollenweider, Franz X.

“…Social ties are crucial for physical and mental health. However, psychiatric patients frequently encounter social rejection. Moreover, an increased reactivity…”
Get full text

Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice by Grandjean, Joanes, Buehlmann, David, Buerge, Michaela, Sigrist, Hannes, Seifritz, Erich, Vollenweider, Franz X., Pryce, Christopher R., Rudin, Markus

“…Hallucinogenic agents have been proposed as potent antidepressants; this includes the serotonin (5-HT) receptor 2A agonist psilocybin. In human subjects,…”
Get full text

Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers by QUEDNOW, Boris B, KOMETER, Michael, GEYER, Mark A, VOLLENWEIDER, Franz X

“…The serotonin-2A receptor (5-HT(2A)R) has been implicated in the pathogenesis of schizophrenia and related inhibitory gating and behavioral inhibition deficits…”
Get full text

Modulation of Social Cognition via Hallucinogens and "Entactogens" by Preller, Katrin H, Vollenweider, Franz X

“…Social cognition is a fundamental ability in human everyday lives. Deficits in social functioning also represent a core aspect of many psychiatric disorders…”
Get full text

Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation by Singer, Berit, Meling, Daniel, Hirsch-Hoffmann, Matthias, Michels, Lars, Kometer, Michael, Smigielski, Lukasz, Dornbierer, Dario, Seifritz, Erich, Vollenweider, Franz X., Scheidegger, Milan

“…In this study, for the first time, we explored a dataset of functional magnetic resonance images collected during focused attention and open monitoring…”
Get full text

Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation by Singer, Berit, Meling, Daniel, Hirsch-Hoffmann, Matthias, Michels, Lars, Kometer, Michael, Smigielski, Lukasz, Dornbierer, Dario, Seifritz, Erich, Vollenweider, Franz X., Scheidegger, Milan

Get full text

Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences by Rieser, Nathalie M., Gubser, Ladina P., Moujaes, Flora, Duerler, Patricia, Lewis, Candace R., Michels, Lars, Vollenweider, Franz X., Preller, Katrin H.

“…Research into the use of psilocybin for the treatment of psychiatric disorders is a growing field. Nevertheless, robust brain–behavior relationships linking…”
Get full text

LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation by Kraehenmann, Rainer, Pokorny, Dan, Aicher, Helena, Preller, Katrin H, Pokorny, Thomas, Bosch, Oliver G, Seifritz, Erich, Vollenweider, Franz X

“…Stimulation of serotonin 2A (5-HT2A) receptors by lysergic acid diethylamide (LSD) and related compounds such as psilocybin has previously been shown to…”
Get full text

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity by Kraehenmann, Rainer, Schmidt, André, Friston, Karl, Preller, Katrin H, Seifritz, Erich, Vollenweider, Franz X

“…Stimulation of serotonergic neurotransmission by psilocybin has been shown to shift emotional biases away from negative towards positive stimuli. We have…”
Get full text

Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD by Burt, Joshua B, Preller, Katrin H, Demirtas, Murat, Ji, Jie Lisa, Krystal, John H, Vollenweider, Franz X, Anticevic, Alan, Murray, John D

“…Psychoactive drugs can transiently perturb brain physiology while preserving brain structure. The role of physiological state in shaping neural function can…”
Get full text

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders by Vollenweider, Franz X., Preller, Katrin H.

“…Renewed interest in the use of psychedelics in the treatment of psychiatric disorders warrants a better understanding of the neurobiological mechanisms…”
Get full text

In vitro and in vivo metabolism of psilocybin's active metabolite psilocin by Thomann, Jan, Kolaczynska, Karolina E, Stoeckmann, Oliver V, Rudin, Deborah, Vizeli, Patrick, Hoener, Marius C, Pryce, Christopher R, Vollenweider, Franz X, Liechti, Matthias E, Duthaler, Urs

“…, psilocybin is rapidly dephosphorylated to psilocin which induces psychedelic effects by interacting with the 5-HT receptor. Psilocin primarily undergoes…”
Get full text

The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval by VOLLENWEIDER, Franz X, CSOMOR, Philipp A, KNAPPE, Bernhard, GEYER, Mark A, QUEDNOW, Boris B

“…Schizophrenia patients exhibit impairments in prepulse inhibition (PPI) of the startle response. Hallucinogenic 5-HT(2A) receptor agonists are used for animal…”
Get full text

Ketamine induces multiple individually distinct whole-brain functional connectivity signatures by Moujaes, Flora, Ji, Jie Lisa, Rahmati, Masih, Burt, Joshua B, Schleifer, Charles, Adkinson, Brendan D, Savic, Aleksandar, Santamauro, Nicole, Tamayo, Zailyn, Diehl, Caroline, Kolobaric, Antonija, Flynn, Morgan, Rieser, Nathalie, Fonteneau, Clara, Camarro, Terry, Xu, Junqian, Cho, Youngsun, Repovs, Grega, Fineberg, Sarah K, Morgan, Peter T, Seifritz, Erich, Vollenweider, Franz X, Krystal, John H, Murray, John D, Preller, Katrin H, Anticevic, Alan

“…Ketamine has emerged as one of the most promising therapies for treatment-resistant depression. However, inter-individual variability in response to ketamine…”
Get full text

Mapping brain-behavior space relationships along the psychosis spectrum by Ji, Jie Lisa, Helmer, Markus, Fonteneau, Clara, Burt, Joshua B, Tamayo, Zailyn, Demšar, Jure, Adkinson, Brendan D, Savić, Aleksandar, Preller, Katrin H, Moujaes, Flora, Vollenweider, Franz X, Martin, William J, Repovš, Grega, Cho, Youngsun T, Pittenger, Christopher, Murray, John D, Anticevic, Alan

“…Difficulties in advancing effective patient-specific therapies for psychiatric disorders highlight a need to develop a stable neurobiologically grounded…”
Get full text

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders by Vollenweider, Franz X, Kometer, Michael

“…In this Perspective, Vollenweider and Kometer discuss the clinical potential of psychedelic drugs for the treatment of various psychiatric disorders, and…”
Get full text